Sildenafil attenuates placental ischemia-induced hypertension

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 305, Issue 4, 2013, Pages

  George, Eric M ^a   Palei, Ana C ^a   Dent, Edward A ^a   Granger, Joey P ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Phosphodiesterase 5; Preeclampsia; Pregnancy; Soluble fms like tyrosine kinase; Vascular endothelial growth factor

Indexed keywords

BETA ACTIN; CYCLIC GMP; PHOSPHODIESTERASE V; SILDENAFIL; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; FEMALE; ISCHEMIA; KIDNEY MEDULLA; MATERNAL HYPERTENSION; NONHUMAN; PLACENTA DISORDER; PLACENTA ISCHEMIA; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT;

PHOSPHODIESTERASE-5; PREECLAMPSIA; PREGNANCY; SOLUBLE FMS-LIKE TYROSINE KINASE; VASCULAR ENDOTHELIAL GROWTH FACTOR;

ACTINS; ADMINISTRATION, ORAL; ANIMALS; ANTIHYPERTENSIVE AGENTS; ARTERIAL PRESSURE; CYCLIC GMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; DISEASE MODELS, ANIMAL; FEMALE; ISCHEMIA; KIDNEY MEDULLA; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PLACENTA; PLACENTAL CIRCULATION; PRE-ECLAMPSIA; PREGNANCY; PURINES; RATS; RATS, SPRAGUE-DAWLEY; SULFONES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASODILATOR AGENTS;

EID: 84881630377     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00216.2013     Document Type: Article

References (41)

1. Abram SR, Alexander BT, Bennett WA, Granger JP. Role of neuronal nitric oxide synthase in mediating renal hemodynamic changes during pregnancy. Am J Physiol Regul Integr Comp Physiol 281: R1390-R1393, 2001.
2. Anumba DO, Robson SC, Boys RJ, Ford GA. Nitric oxide activity in the peripheral vasculature during normotensive and preeclamptic pregnancy. Am J Physiol Heart Circ Physiol 277: H848-H854, 1999.
3. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JE, Mosher MD. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 7: 566-571, 1993.
4. Coppage KH, Sun X, Baker RS, Clark KE. Expression of phosphodi-esterase 5 in maternal and fetal sheep. Am J Obstet Gynecol 193: 1005-1010, 2005.
5. Crews JK, Herrington JN, Granger JP, Khalil RA. Decreased endo-thelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. Hypertension 35: 367-372, 2000.
6. Dai ZK, Tan MS, Chai CY, Chou SH, Lin PC, Yeh JL, Jeng AY, Chang CI, Chen IJ, Wu JR. Effects of sildenafil on pulmonary hypertension and levels of ET-1, eNOS, and cGMP in aorta-banded rats. Exp Biol Med (Maywood) 231: 942-947, 2006.
7. Danielson LA, Conrad KP. Acute blockade of nitric oxide synthase inhibits renal vasodilation and hyperfiltration during pregnancy in chronically instrumented conscious rats. J Clin Invest 96: 482-490, 1995.
8. Downing J. Sildenafil for the treatment of preeclampsia. Hypertens Pregnancy 29: 248-250; author reply 251-242, 2010.
9. Gadonski G, LaMarca BB, Sullivan E, Bennett W, Chandler D, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. Hypertension 48: 711-716, 2006.
10. Gilbert JS, Babcock SA, Granger JP. Hypertension produced by reduced uterine perfusion in pregnant rats is associated with increased soluble fms-like tyrosine kinase-1 expression. Hypertension 50: 1142-1147, 2007.
11. Gilbert JS, Gilbert SA, Arany M, Granger JP. Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression. Hypertension 53: 399-403, 2009.
12. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ Physiol 294: H541-H550, 2008.
13. Granger JP, LaMarca BB, Cockrell K, Sedeek M, Balzi C, Chandler D, Bennett W. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia. Methods Mol Med 122: 383-392, 2006.
14. Herraiz S, Pellicer B, Serra V, Cauli O, Cortijo J, Felipo V, Pellicer A. Sildenafil citrate improves perinatal outcome in fetuses from pre-eclamptic rats. BJOG 119: 1394-1402, 2012.
15. Karumanchi SA, Epstein FH. Placental ischemia and soluble fms-like tyrosine kinase 1: cause or consequence of preeclampsia? Kidney Int 71: 959-961, 2007.
16. Khalil RA, Crews JK, Novak J, Kassab S, Granger JP. Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. Hypertension 31: 1065-1069, 1998.
17. Khong Y, Brosens I. Defective deep placentation. Best Pract Res Clin Obstet Gynaecol 25: 301-311, 2011.
18. Knight S, Snellen H, Humphreys M, Baylis C. Increased renal phos-phodiesterase-5 activity mediates the blunted natriuretic response to ANP in the pregnant rat. Am J Physiol Renal Physiol 292: F655-F659, 2007.
19. LaMarca B, Speed J, Fournier L, Babcock SA, Berry H, Cockrell K, Granger JP. Hypertension in response to chronic reductions in uterine perfusion in pregnant rats: effect of tumor necrosis factor-alpha blockade. Hypertension 52: 1161-1167, 2008.
20. LaMarca B, Wallukat G, Llinas M, Herse F, Dechend R, Granger JP. Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats. Hypertension 52: 1168-1172, 2008.
21. LaMarca BB, Bennett WA, Alexander BT, Cockrell K, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alpha. Hypertension 46: 1022-1025, 2005.
22. Lyall F, Young A, Greer IA. Nitric oxide concentrations are increased in the fetoplacental circulation in preeclampsia. Am J Obstet Gynecol 173: 714-718, 1995.
23. Makris A, Thornton C, Thompson J, Thomson S, Martin R, Ogle R, Waugh R, McKenzie P, Kirwan P, Hennessy A. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int 71: 977-984, 2007.
24. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Liber-mann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and pro-teinuria in preeclampsia. J Clin Invest 111: 649-658, 2003.
25. Meis PJ, Goldenberg RL, Mercer BM, Iams JD, Moawad AH, Mi-odovnik M, Menard MK, Caritis SN, Thurnau GR, Bottoms SF, Das A, Roberts JM, McNellis D. The preterm prediction study: risk factors for indicated preterm births. Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. Am J Obstet Gynecol 178: 562-567, 1998.
26. Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, protein-uria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 170: 1458-1466, 1994.
27. Murphy SR, LaMarca BB, Cockrell K, Granger JP. Role of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant rats. Hypertension 55: 394-398, 2010.
28. Ni XP, Safai M, Rishi R, Baylis C, Humphreys MH. Increased activity of cGMP-specific phosphodiesterase (PDE5) contributes to resistance to atrial natriuretic peptide natriuresis in the pregnant rat. J Am Soc Nephrol 15: 1254-1260, 2004.
29. Ramesar SV, Mackraj I, Gathiram P, Moodley J. Sildenafil citrate decreases sFlt-1 and sEng in pregnant l-NAME treated Sprague-Dawley rats. Eur J Obstet Gynecol Reprod Biol 157: 136-140, 2011.
30. Ramesar SV, Mackraj I, Gathiram P, Moodley J. Sildenafil citrate improves fetal outcomes in pregnant, l-NAME treated, Sprague-Dawley rats. Eur J Obstet Gynecol Reprod Biol 149: 22-26, 2010.
31. Roberts JM, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 41: 437-445, 2003.
32. Samangaya RA, Mires G, Shennan A, Skillern L, Howe D, McLeod A, Baker PN. A randomised, double-blinded, placebo-controlled study of the phosphodiesterase type 5 inhibitor sildenafil for the treatment of pre-eclampsia. Hypertens Pregnancy 28: 369-382, 2009.
33. Sasser JM, Baylis C. Effects of sildenafil on maternal hemodynamics and fetal growth in normal rat pregnancy. Am J Physiol Regul Integr Comp Physiol 298: R433-R438, 2010.
34. Sasser JM, Ni XP, Humphreys MH, Baylis C. Increased renal phos-phodiesterase-5 activity mediates the blunted natriuretic response to a nitric oxide donor in the pregnant rat. Am J Physiol Renal Physiol 299: F810-F814, 2010.
35. Sedeek M, Gilbert JS, LaMarca BB, Sholook M, Chandler DL, Wang Y, Granger JP. Role of reactive oxygen species in hypertension produced by reduced uterine perfusion in pregnant rats. Am J Hypertens 21: 1152-1156, 2008.
36. Sholook MM, Gilbert JS, Sedeek MH, Huang M, Hester RL, Granger JP. Systemic hemodynamic and regional blood flow changes in response to chronic reductions in uterine perfusion pressure in pregnant rats. Am J Physiol Heart Circ Physiol 293: H2080-H2084, 2007.
37. Stanley JL, Andersson IJ, Poudel R, Rueda-Clausen CF, Sibley CP, Davidge ST, Baker PN. Sildenafil citrate rescues fetal growth in the catechol-O-methyl transferase knockout mouse model. Hypertension 59: 1021-1028, 2012.
38. Turner JA. Diagnosis and management of pre-eclampsia: an update. Int J Womens Health 2: 327-337, 2010.
39. Wareing M, Myers JE, O'Hara M, Kenny LC, Warren AY, Taggart MJ, Skillern L, Machin I, Baker PN. Effects of a phosphodiesterase-5 (PDE5) inhibitor on endothelium-dependent relaxation of myometrial small arteries. Am J Obstet Gynecol 190: 1283-1290, 2004.
40. 2+ handling dysfunction in right ventricle failure induced by pulmonary artery hypertension. Hypertension 59: 355-362, 2012.
41. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 169: 1316-1320, 1993.